Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Plasma platelet activating factor in nephrotic syndrome.

M Camici¹, A Sagripanti

¹Department of Internal Medicine, University of the Study, Pisa, Italy.

|October 25, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ocular involvement in monkeypox: Description of an unusual presentation during the current outbreak.

The Journal of infection·2022

Same author

A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017

Same author

Cell proliferation and drug sensitivity of human glioblastoma cells are altered by the stable modulation of cytosolic 5'-nucleotidase II.

The international journal of biochemistry & cell biology·2015

Same author

The purine analog fludarabine acts as a cytosolic 5'-nucleotidase II inhibitor.

Biochemical pharmacology·2015

Same author

Partial purification and characterization of a proteolytic activity of alfalfa juice.

Journal of agricultural and food chemistry·2009

Same author

The phosphotransferase activity of cytosolic 5'-nucleotidase; a purine analog phosphorylating enzyme.

The international journal of biochemistry & cell biology·2009

Platelet-activating factor (PAF) levels are significantly higher in patients with nephrotic syndrome. This suggests PAF may play a role in the development of glomerular proteinuria.

Area of Science:

Nephrology
Biochemistry
Pathophysiology

Background:

The underlying mechanisms driving proteinuria in nephrotic syndrome remain unclear.
Investigating the role of specific biomolecules like platelet-activating factor (PAF) is crucial for understanding disease pathogenesis.

Purpose of the Study:

To evaluate plasma levels of platelet-activating factor (PAF) in individuals with nephrotic syndrome compared to healthy controls.
To explore the potential involvement of PAF in the development of glomerular proteinuria.

Main Methods:

Plasma samples were collected from 21 patients diagnosed with nephrotic proteinuria and 20 healthy individuals.
Platelet-activating factor (PAF) concentrations were quantified using a ((125)I) radioimmunoassay (RIA) kit.

Related Experiment Videos

Main Results:

Patients with glomerular proteinuria exhibited significantly elevated plasma PAF bioactivity (116.28 ± 49.6 ng/ml) compared to normal subjects (41.4 ± 14.9 ng/ml).
The observed increase in PAF levels was statistically significant (p<0.05).

Conclusions:

The findings indicate a potential association between elevated plasma PAF and the pathogenesis of human glomerular proteinuria.
Platelet-activating factor (PAF) may be implicated as a contributing factor in the development of nephrotic syndrome.